|
CN102464654B
(zh)
|
2010-11-12 |
2016-01-13 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
|
EP2729448B1
(en)
|
2011-07-06 |
2015-09-09 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
|
CA2897268C
(en)
|
2013-01-09 |
2018-12-04 |
Gilead Sciences, Inc. |
Therapeutic compounds for the treatment of viral infections
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
CA2896244C
(en)
|
2013-01-09 |
2017-07-04 |
Gilead Sciences, Inc. |
5-membered heteroaryls and their use as antiviral agents
|
|
TWI694071B
(zh)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
|
|
EP3060554A1
(en)
|
2013-10-24 |
2016-08-31 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
WO2015130966A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Antiviral agents
|
|
WO2015130964A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
PT3186239T
(pt)
|
2014-08-29 |
2019-01-10 |
Gilead Sciences Inc |
Agentes antirretrovirais
|
|
US9855230B2
(en)
|
2014-09-09 |
2018-01-02 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
CN107995910A
(zh)
|
2015-04-23 |
2018-05-04 |
Viiv保健英国第五有限公司 |
人免疫缺陷病毒复制的抑制剂
|
|
BR112017022605A2
(pt)
|
2015-04-23 |
2018-07-17 |
Viiv Healthcare Uk No 5 Ltd |
?composto, composição, e, método para tratamento de infecção por hiv?.
|
|
KR20230011471A
(ko)
|
2016-08-19 |
2023-01-20 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물
|
|
TW201906834A
(zh)
*
|
2017-05-02 |
2019-02-16 |
英商Viiv醫療保健英國(No.5)有限公司 |
人類免疫不全病毒複製之抑制劑
|
|
TWI687415B
(zh)
|
2017-08-17 |
2020-03-11 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
|
US10836746B2
(en)
|
2018-02-15 |
2020-11-17 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
WO2019161280A1
(en)
|
2018-02-16 |
2019-08-22 |
Gilead Sciences, Inc. |
Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection
|
|
WO2019198024A1
(en)
*
|
2018-04-11 |
2019-10-17 |
VIIV Healthcare UK (No.5) Limited |
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
|
|
JP7433303B2
(ja)
*
|
2018-09-20 |
2024-02-19 |
ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド |
ヒト免疫不全ウイルス複製の阻害剤
|
|
EP3873607B1
(en)
*
|
2018-10-29 |
2023-11-29 |
VIIV Healthcare UK (No.5) Limited |
Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replication
|
|
US20210379071A1
(en)
*
|
2018-11-05 |
2021-12-09 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
WO2020095177A1
(en)
*
|
2018-11-05 |
2020-05-14 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
UY38559A
(es)
*
|
2019-02-01 |
2020-07-31 |
Viiv Healthcare Uk No 5 Ltd |
Inhibidores de la replicación del virus de la inmunodeficiencia humana
|
|
LT3986561T
(lt)
*
|
2019-06-19 |
2024-04-25 |
VIIV Healthcare UK (No.5) Limited |
Pirido[2,3-d]pirimidino dariniai kaip žmogaus imunodeficito viruso replikacijos inhibitoriai
|
|
UY38982A
(es)
*
|
2019-12-09 |
2021-06-30 |
Viiv Healthcare Co |
Composiciones farmacéuticas
|